Login / Register
MS Validated Antibodies - Logo
  • About us
  • Products
    • Primary antibodies
    • Gallery
  • Distributors
  • Validation
    • Tissue Microarrays
  • Publications
    • Large Scale Studies
    • Further Publications
    • Events
    • Quiz
  • Contact
  • About us
  • Products
    • Primary antibodies
    • Gallery
  • Distributors
  • Validation
    • Tissue Microarrays
  • Publications
    • Large Scale Studies
    • Further Publications
    • Events
    • Quiz
  • Contact
×

Cancer Tissue Gallery MCM5

Path Created with Sketch.
Go to MCM5 Normal Tissue GalleryGo back to Product Page
Breast – Invasive breast cancer of no special type (NST) with weak to moderate nuclear MCM5 staining of a large subset of tumor cells.
Breast – Invasive breast cancer of no special type (NST) with weak to moderate nuclear MCM5 staining of a large subset of tumor cells.
Breast – Invasive lobular breast cancer with moderate to strong nuclear MCM5 positivity of most tumor cells.
Breast – Invasive lobular breast cancer with moderate to strong nuclear MCM5 positivity of most tumor cells.
Colon – Colorectal adenocarcinoma with moderate to strong nuclear MCM5 staining of a subset of tumor cells.
Colon – Colorectal adenocarcinoma with moderate to strong nuclear MCM5 staining of a subset of tumor cells.
Colon – Colorectal adenocarcinoma with strong MCM5 positivity of a large fraction of tumor cells.
Colon – Colorectal adenocarcinoma with strong MCM5 positivity of a large fraction of tumor cells.
Kidney – Clear cell renal cell carcinoma with MCM5 staining at variable intensity of a significant subset of tumor cells.
Kidney – Clear cell renal cell carcinoma with MCM5 staining at variable intensity of a significant subset of tumor cells.
Kidney – Oncocytoma with distinct nuclear MCM5 staining of a large subset of tumor cells. .jpeg
Kidney – Oncocytoma with distinct nuclear MCM5 staining of a large subset of tumor cells.
Kidney – Oncocytoma with weak to moderate nuclear MCM5 staining of a fraction of tumor cells.
Kidney – Oncocytoma with weak to moderate nuclear MCM5 staining of a fraction of tumor cells.
Kidney – Papillary renal cell carcinoma with distinct nuclear MCM5 staining of a fraction of tumor cells.
Kidney – Papillary renal cell carcinoma with distinct nuclear MCM5 staining of a fraction of tumor cells.
Kidney – Papillary renal cell carcinoma with strong MCM5 staining of a subset of tumor cells. .jpeg
Kidney – Papillary renal cell carcinoma with strong MCM5 staining of a subset of tumor cells.
Lung – Adenocarcinoma with strong nuclear MCM5 staining of a fraction of tumor cells. .jpeg
Lung – Adenocarcinoma with strong nuclear MCM5 staining of a fraction of tumor cells.
Lung – Adenocarcinoma with weak to moderate MCM5 staining of a subset of tumor cells.
Lung – Adenocarcinoma with weak to moderate MCM5 staining of a subset of tumor cells.
Lung – Malignant mesothelioma with MCM5 positivity of a fraction of a subset of tumor cells.
Lung – Malignant mesothelioma with MCM5 positivity of a fraction of a subset of tumor cells.
Lung – Squamous cell carcinoma with moderate to strong nuclear MCM5 staining of a significant fraction of tumor cells.
Lung – Squamous cell carcinoma with moderate to strong nuclear MCM5 staining of a significant fraction of tumor cells.
Lung – Squamous cell carcinoma with strong MCM5 staining of a subset of tumor cells. .jpeg
Lung – Squamous cell carcinoma with strong MCM5 staining of a subset of tumor cells.
Oral cavity – Squamous cell carcinoma with distinct nucler MCM5 staining of a subset of tumor cells, preferentially at the periphery of tumor cell nests. .jpeg
Oral cavity – Squamous cell carcinoma with distinct nucler MCM5 staining of a subset of tumor cells, preferentially at the periphery of tumor cell nests.
Ovary – Clear cell carcinoma with weak MCM5 staining of a subset of tumor cells.
Ovary – Clear cell carcinoma with weak MCM5 staining of a subset of tumor cells.
Ovary – Clear cell carcinoma with weak to moderate nuclear MCM5 positivity of a fraction of tumor cells.
Ovary – Clear cell carcinoma with weak to moderate nuclear MCM5 positivity of a fraction of tumor cells.
Ovary – Serous high-grade carcinoma with strong nuclear MCM5 staining of _90 of tumor cells.
Ovary – Serous high-grade carcinoma with strong nuclear MCM5 staining of _90 of tumor cells.
Ovary – Serous high-grade carcinoma with variable intensity nuclear MCM5 staining of almost all tumor cells.
Ovary – Serous high-grade carcinoma with variable intensity nuclear MCM5 staining of almost all tumor cells.
Pharynx – Squamous cell carcinoma with distinct nuclear MCM5 staining of _90_ of tumor cells. .jpeg
Pharynx – Squamous cell carcinoma with distinct nuclear MCM5 staining of _90_ of tumor cells.
Pharynx – Squamous cell carcinoma with moderate to strong MCM5 positivity of all tumor cells.
Pharynx – Squamous cell carcinoma with moderate to strong MCM5 positivity of all tumor cells.
Prostate – Adenocarcinoma (Gleason 3+3=6) with strong MCM5 positivity of a subset of tumor cells.
Prostate – Adenocarcinoma (Gleason 3+3=6) with strong MCM5 positivity of a subset of tumor cells.
Prostate – Adenocarcinoma (Gleason 3+4=7) with distinct MCM5 staining of a small subset of tumor cells.
Prostate – Adenocarcinoma (Gleason 3+4=7) with distinct MCM5 staining of a small subset of tumor cells.
Prostate – Adenocarcinoma (Gleason 9) with distinct nuclear MCM5 postitivity of a subset of tumor cells. .jpeg
Prostate – Adenocarcinoma (Gleason 9) with distinct nuclear MCM5 postitivity of a subset of tumor cells.
Testis – Seminoma with moderate to strong MCM5 immunostaining of a large subset of tumor cells.
Testis – Seminoma with moderate to strong MCM5 immunostaining of a large subset of tumor cells.
Thyroid – Papillary cancer with weak to moderate nuclear MCM5 staining of a fraction of tumor cells.
Thyroid – Papillary cancer with weak to moderate nuclear MCM5 staining of a fraction of tumor cells.
Urinary bladder – Micropapillary muscle-invasive urothelial carcinoma with strong MCM5 positivity of _80_ of tumor cells.
Urinary bladder – Micropapillary muscle-invasive urothelial carcinoma with strong MCM5 positivity of _80_ of tumor cells.
Urinary bladder – Muscle-invasive urothelial carcinoma with strong MCM5 staining of a large subset of tumor cells.
Urinary bladder – Muscle-invasive urothelial carcinoma with strong MCM5 staining of a large subset of tumor cells.
Urinary bladder – Muscle-invasive urothelial carcinoma with strong MCM5 staining of all tumor cells.
Urinary bladder – Muscle-invasive urothelial carcinoma with strong MCM5 staining of all tumor cells.
Urinary bladder – Non-invasive urothelial carcinoma (low grade, pTaG2) with distinct MCM5 staining of few tumor cells.
Urinary bladder – Non-invasive urothelial carcinoma (low grade, pTaG2) with distinct MCM5 staining of few tumor cells.
  • Linkedin
  • My Account
  • Search
    ×
  • Cart 0
© 2025 MS Validated Antibodies
  • Imprint
  • Privacy Policy
  • Distributors